| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, Queen's University, and The Special Investigation Unit, Kingston General Hospital, Kingston, Ontario, Canada
In a study of the effect of the administration of hydroxyurea in doses of 100200 mg/kg/day on erythropoiesis, erythrocyte survival, and erythrokinetics, 10 of 12 rabbits developed a normocytic anemia, a decrease in plasma iron transport rate, and a reduction in red cell iron uptake, but no significant change in erythrocyte survival. The anemia was reversible and prompt recovery occurred when the drug was stopped. In 2 animals the anemia was associated with a moderate shortening of erythrocyte survival without a reduction in the plasma iron transport rate or the red cell iron uptake. In animals with phenylhydrazine-induced hemolytic anemia, hydroxyurea in a dose of 200 mg/kg/day impaired erythropoiesis, but it did not block the production of macrocytic erythrocytes in response to the erythropoietic stress.
1 Supported by a grant from The Medical Research Council of Canada and the Clare Nelson Bequest.
2 Research Fellow, Medical Research Council of Canada.
Received 3/11/68. Accepted 5/ 6/68.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |